{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:34:44Z","timestamp":1767792884951,"version":"3.49.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"R&D Program of Guangzhou National Laboratory","award":["SRPG22-018"],"award-info":[{"award-number":["SRPG22-018"]}]},{"name":"AstraZeneca China","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,4,29]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) often experience rapid declines in lung function but are rarely treated early. The Prospect of early InterventiON in the managEment of chronic obstructivE pulmonaRy disease (PIONEER) study aims to evaluate the efficacy of long-term glycopyrrolate\/formoterol fumarate (GFF) metered dose inhaler (MDI) as an initial therapy on lung function and disease progression in individuals with mild-to-moderate COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This is a multicentre, randomised, double-blind, placebo-controlled, parallel-group study. Approximately 318 patients with COPD in Global Initiative for Chronic Obstructive Lung Disease stages 1 (mild) or 2 (early moderate), with no history of severe exacerbations in the previous year, will be randomised in a 2:1 ratio to receive two times per day GFF MDI (14.4\/10\u2009\u00b5g) or placebo for 52 weeks. Clinical assessments will include pulmonary function tests, symptom scores, quality-of-life measures, recording of COPD exacerbations and chest CT. The primary endpoint is the between-group difference in the change from baseline in forced expiratory volume in 1\u2009s (FEV\n                      <jats:sub>1<\/jats:sub>\n                      ) after 2\u2009hours of bronchodilator over 24 weeks. Secondary endpoints include the between-group difference in the change from baseline in morning pre-dose trough FEV\n                      <jats:sub>1<\/jats:sub>\n                      over 24 weeks, morning post-dose 2\u2009hour FEV\n                      <jats:sub>1<\/jats:sub>\n                      over 52 weeks and time to minimal clinically important deterioration. The safety endpoint is the incidence of adverse events. An extension study with rerandomisation will follow the PIONEER study to explore the long-term need for GFF MDI use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ChiCTR2200064765; Chinese Clinical Trial Registry,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"www.chictr.org.cn\">www.chictr.org.cn<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol has been approved by the Ethics Committee of The First Affiliated Hospital, Guangzhou Medical University (2022-23\u30012024-K-005), and all collaborating centres have obtained approval from their respective ethics committees. Results will be presented at national and international meetings and submitted for publication in peer-reviewed journals within the field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002656","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T19:25:18Z","timestamp":1750015518000},"page":"e002656","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Glycopyrrolate\/formoterol fumarate MDI in mild-to-moderate chronic obstructive pulmonary disease (PIONEER): a protocol for a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-0625","authenticated-orcid":false,"given":"Feng-Yan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Xuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Yu","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6651-634X","authenticated-orcid":false,"given":"Pi-Xin","family":"Ran","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"},{"name":"Guangzhou National Laboratory, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0555-8391","authenticated-orcid":false,"given":"Yu-Min","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"},{"name":"Guangzhou National Laboratory, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Juan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Yi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Chang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"},{"name":"Hetao Institute of Guangzhou National Laboratory, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2877-2475","authenticated-orcid":false,"given":"Wei-Jie","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"},{"name":"Guangzhou National Laboratory, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Shan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"},{"name":"Guangzhou National Laboratory, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ping","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China"},{"name":"Guangzhou National Laboratory, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,15]]},"reference":[{"key":"2026010701503184000_12.1.e002656.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00511-7"},{"key":"2026010701503184000_12.1.e002656.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m234","article-title":"Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the global burden of disease study 2017","volume":"368","author":"Li","year":"2020","journal-title":"BMJ"},{"key":"2026010701503184000_12.1.e002656.3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S2213-2600(18)30103-6","article-title":"Chronic obstructive pulmonary disease in China: a nationwide prevalence study","volume":"6","author":"Fang","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026010701503184000_12.1.e002656.4","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","article-title":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study CPH] study): a national cross-sectional study","volume":"391","author":"Wang","year":"2018","journal-title":"The Lancet"},{"key":"2026010701503184000_12.1.e002656.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201511-2219OC"},{"key":"2026010701503184000_12.1.e002656.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203270"},{"key":"2026010701503184000_12.1.e002656.7","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-3-56","article-title":"Health-related quality of life is related to COPD disease severity","volume":"3","author":"St\u00e5hl","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"2026010701503184000_12.1.e002656.8","unstructured":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseas. 2023. Available: https:\/\/goldcopd.org"},{"key":"2026010701503184000_12.1.e002656.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030415"},{"key":"2026010701503184000_12.1.e002656.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700228"},{"key":"2026010701503184000_12.1.e002656.11","article-title":"Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis","volume":"12","author":"Oba","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010701503184000_12.1.e002656.12","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1193-9","article-title":"Efficacy of umeclidinium\/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial","volume":"20","author":"Maltais","year":"2019","journal-title":"Respir Res"},{"key":"2026010701503184000_12.1.e002656.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.05.016"},{"key":"2026010701503184000_12.1.e002656.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00200212"},{"key":"2026010701503184000_12.1.e002656.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00136014"},{"key":"2026010701503184000_12.1.e002656.16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2017.02.008","article-title":"A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium\/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease","volume":"125","author":"D\u2019Urzo","year":"2017","journal-title":"Respir Med"},{"key":"2026010701503184000_12.1.e002656.17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.chest.2016.11.028","article-title":"Efficacy and safety of glycopyrrolate\/formoterol metered dose inhaler formulated using co-suspension delivery technology in patients with COPD","volume":"151","author":"Martinez","year":"2017","journal-title":"Chest"},{"key":"2026010701503184000_12.1.e002656.18","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2147\/COPD.S171835","article-title":"Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate\/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA","volume":"13","author":"Lipworth","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026010701503184000_12.1.e002656.19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.rmed.2017.03.015","article-title":"Long-term safety and efficacy of glycopyrrolate\/formoterol metered dose inhaler using novel co-suspension delivery technology in patients with chronic obstructive pulmonary disease","volume":"126","author":"Hanania","year":"2017","journal-title":"Respir Med"},{"key":"2026010701503184000_12.1.e002656.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-3-201108020-00008"},{"key":"2026010701503184000_12.1.e002656.21","first-page":"170","article-title":"Chronic obstructive pulmonary disease group of chinese thoracic society; chronic obstructive pulmonary disease committee of chinese association of chest physician. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021)","volume":"44","year":"2021","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2026010701503184000_12.1.e002656.22","doi-asserted-by":"crossref","unstructured":"Halpin D , Papi A , et al . Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020;24\u201336. doi:10.1164\/rccm.202009-3533SO","DOI":"10.1164\/rccm.202009-3533SO"},{"key":"2026010701503184000_12.1.e002656.23","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2971"},{"key":"2026010701503184000_12.1.e002656.24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201811-2083OC","article-title":"Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease","volume":"200","author":"Vasilescu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010701503184000_12.1.e002656.25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa2204752","article-title":"Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function","volume":"387","author":"Han","year":"2022","journal-title":"N Engl J Med"},{"key":"2026010701503184000_12.1.e002656.26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/resp.14357","article-title":"Dual bronchodilator treatment for prevention of COPD in at-risk smokers","volume":"27","author":"Thamrin","year":"2022","journal-title":"Respirology"},{"key":"2026010701503184000_12.1.e002656.27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00351-2019","article-title":"Assessing global COPD awareness with Google Trends","volume":"53","author":"Boehm","year":"2019","journal-title":"Eur Respir J"},{"key":"2026010701503184000_12.1.e002656.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00025905"},{"key":"2026010701503184000_12.1.e002656.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001295","article-title":"COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation","volume":"9","author":"Pal","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"2026010701503184000_12.1.e002656.30","doi-asserted-by":"crossref","unstructured":"Xu G , Fan G , Niu W . COPD awareness and treatment in China. Lancet Respir Med 2018;6. doi:10.1016\/S2213-2600(18)30200-5","DOI":"10.1016\/S2213-2600(18)30200-5"},{"key":"2026010701503184000_12.1.e002656.31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30155-7"},{"key":"2026010701503184000_12.1.e002656.32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/resp.13176","article-title":"Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure","volume":"23","author":"Zhao","year":"2018","journal-title":"Respirology"},{"key":"2026010701503184000_12.1.e002656.33","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.700836","article-title":"The \u201cslow horse racing effect\u201d on lung function in adult life in chronic obstructive pulmonary disease associated to biomass exposure","volume":"8","author":"Ram\u00edrez-Venegas","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026010701503184000_12.1.e002656.34","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01662-7","article-title":"Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function","volume":"22","author":"Li","year":"2021","journal-title":"Respir Res"},{"key":"2026010701503184000_12.1.e002656.35","doi-asserted-by":"crossref","unstructured":"At the root: defining and halting progression of early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2018;1540\u201351. doi:10.1164\/rccm.201710-2028PP","DOI":"10.1164\/rccm.201710-2028PP"},{"key":"2026010701503184000_12.1.e002656.36","first-page":"384","article-title":"Copdgene 2019: redefining the diagnosis of chronic obstructive pulmonary disease","volume":"6","author":"Lowe","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026010701503184000_12.1.e002656.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201612-2531OC"},{"key":"2026010701503184000_12.1.e002656.38","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00175-2018","article-title":"Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study","volume":"5","author":"Li","year":"2019","journal-title":"ERJ Open Res"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:51:08Z","timestamp":1767779468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,15]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjresp-2024-002656"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002656","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}